Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SET1B is a component of a histone methyltransferase complex that produces trimethylated histone H3 at Lys4 (Lee et al., 2007 [PubMed 17355966]).[supplied by OMIM, Mar 2008]..
Showing 10 out of 27 products:
we propose histone demethylase (show MBD2 Antibodies) KDM2B (show KDM2B Antibodies) and histone methyltransferase SETD1B as the two most plausible candidate genes involved in intellectual disability, autism, epilepsy, and craniofacial anomalies
We analyzed SETD1B expression in gastric and colorectal cancer. Loss of SETD1B was identified in 15% to 55% of the GC and CRC (show CALR Antibodies) with respect to the microsatellite instability status. Loss of expression was more common in those with SETD1B mutations.
both Rbm15 (show RBM15 Antibodies) and the leukemogenic Rbm15 (show RBM15 Antibodies)-Mkl1 (show MKL1 Antibodies) fusion protein interact with the Setd1b histone H3 (show HIST3H3 Antibodies)-Lys4 methyltransferase
The H3K4 methyltransferase Setd1a (show SETD1A Antibodies) is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation.
SET1B is a component of a histone methyltransferase complex that produces trimethylated histone H3 at Lys4 (Lee et al., 2007
SET domain-containing protein 1B
, histone-lysine N-methyltransferase SETD1B
, lysine N-methyltransferase 2G